Our Pick Of The Best Penny Stocks In November 2026Simplywall·Nov 15, 2026 at 06:29 AM00241+2.45%003380.00%
The "Ping An Circle" has signed a deep cooperation agreement with YIXINTANG, JZJ, and Guizhou Yishu, three major regional chains36Kr·Mar 16, 2026 at 03:46 AM01833+1.12%510660-0.88%
CITIC Construction Investment: The pharmacy industry is currently recovering moderately, and transformation is expected to catalyze valuation enhancementZhitong·Sep 10, 2025 at 06:16 AM605266+0.53%002727+2.65%
JZJ: The shareholding ratio of the actual controller and controlling shareholder has increased to 40.7056%Zhitong·Jul 1, 2025 at 08:13 AM605266+0.53%
China Post Securities: The retail pharmacy industry continues to clear out, and the ongoing coordination is expected to bring performance growthZhitong·Jul 1, 2025 at 06:57 AM603233+0.83%605266+0.53%
Pharmaceutical commercial stocks opened strong, with YIXINTANG hitting the limit up, Hezong Medicine Easy-To-Buy Pharmaceutical rising over 10%, and JZJ, Saili Medical, Huaren Health, SYPM, and others following suitWallstreetcn·May 21, 2025 at 01:32 AM300937-0.68%605266+0.53%
Zhitong A-share lock-up release overview | April 29Zhitong·Apr 29, 2025 at 01:01 AM603299+0.12%603456-1.47%
JZJ: Net profit in the first quarter of 2025 decreased by 35.85% year-on-yearZhitong·Apr 28, 2025 at 02:29 PM605266+0.53%
Closing Review: Three major stock indices slightly declined, and the pharmaceutical commercial concept remained activeZhitong·Mar 10, 2025 at 07:02 AM605266+0.53%603716+1.00%
The pharmaceutical commercial sector is active against the trend, LBX hits the daily limit in the afternoonZhitong·Mar 10, 2025 at 05:34 AM301017-3.64%603939+1.81%
JZJ spent CNY 94.9581 million to complete the repurchase of 2.77% of its sharesZhitong·Feb 5, 2025 at 09:05 AM605266+0.53%
JZJ: Net profit is expected to decrease by 68.78% to 65.50% in 2024Zhitong·Jan 17, 2025 at 11:25 AM605266+0.53%
The pharmaceutical commercial concept fluctuates downward, HRPC approaches the limit downZhitong·Jan 7, 2025 at 05:09 AM300937-0.68%605266+0.53%